$OMDA

Cook Steven L. sold $292K of OMDA

Cook Steven L. (Chief Financial Officer) sold 12,150 shares of Omada Health, Inc. (OMDA) at an average of $24.01 ($24.00–$24.01, $0.29M total) across 2 trades on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Jul 17, 2026, 8:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 17, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
medium confidence
Mentioned
$OMDA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosed sale is unlikely to change the company’s fundamentals, but it provides a fresh datapoint on insider activity.

02

Market read

Traders may monitor insider activity for sentiment, but this specific filing lacks new company-specific fundamentals.

03

What to watch

Check whether there is a pattern of repeated insider sales across multiple filings, and whether any other contemporaneous disclosures (earnings, guidance, financing) exist.

Relevance 3/10Novelty 3/10Timing: new Form 4 filed after-hours (filed 2026-07-17)

Background

The article is an SEC Form 4 insider transaction disclosure for Omada Health, Inc.

Company-level read

Ticker impact

$OMDANeutralMedium confidence
Context

Omada Health CFO Steven L. Cook sold 12,150 shares in open-market transactions at about $24.01 per share under a 10b5-1 plan.

Expected impact

Likely limited, short-lived impact unless follow-on insider selling accelerates or coincides with other negative news.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan; the article provides no new operational, financial, or regulatory developments.

Market effects

No clear sector read-through from a single CFO 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

A 10b5-1 sale is often mechanical and may not reflect bearish expectations; the CFO may be diversifying or funding personal liquidity needs.

Key entities

  • Omada Health, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Steven L. Cook

    Chief Financial Officer who sold shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch